Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study protocol document version on the page was updated from v3.6.5 to v3.6.6, indicating a newer protocol release. This reflects an administrative update to the Study Protocol and Statistical Analysis Plan documentation on the page.
    Difference
    0.0%
    Check dated 2026-08-29T18:44:01.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The study’s locations were updated with many new enrollment sites across China (e.g., Hangzhou, Shanghai, Chengdu, Jinan, Nanjing, Shenyang, Qingdao, Hangzhou again) and other regions, while a large number of previously listed sites were removed, resulting in a larger overall footprint (up to 380 locations) compared to before.
    Difference
    4%
    Check dated 2026-08-15T11:20:00.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a newer release. There is no indication of user-facing content changes to study details or page layout.
    Difference
    0.0%
    Check dated 2026-08-08T03:58:51.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing Revision: v3.6.3, signaling a minor page-version update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-07-24T22:17:17.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    A new platform revision tag v3.6.3 was added, replacing v3.6.2, indicating a software update rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-07-03T14:51:41.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    New recruitment, sponsor, and study-document links were added to the Study Details page. Items include BMS Clinical Trial Patient Recruiting, BMS Clinical Trial Information, Mirati Therapeutics Inc., and a PDF of the Study Protocol and Statistical Analysis Plan, along with IPD data-sharing notes.
    Difference
    100%
    Check dated 2026-06-26T10:22:26.000Z thumbnail image

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.